Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement:: hematological, nephrological, and otological studies of heterozygous KO mice

被引:47
作者
Matsushita, T [1 ]
Hayashi, H
Kunishima, S
Hayashi, M
Ikejiri, M
Takeshita, K
Yuzawa, Y
Adachi, T
Hirashimi, K
Sone, M
Yamamoto, K
Takagi, A
Katsumi, A
Kawai, K
Nezu, T
Takahashi, M
Nakashima, T
Naoe, T
Kojima, T
Saito, H
机构
[1] Nagoya Univ, Grad Sch Med, Dept Hematol, Nagoya, Aichi, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Otorhinolaryngol, Nagoya, Aichi, Japan
[3] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi, Japan
[4] Nagoya Univ, Grad Sch Med, Dept Internal Med, Dept Clin Immunol, Nagoya, Aichi, Japan
[5] Nagoya Univ, Sch Hlth Sci, Dept Med Technol, Nagoya, Aichi, Japan
[6] Nagoya Med Ctr, Clin Res Ctr, Dept Hemostasis & Thrombosis, Nagoya, Aichi, Japan
[7] Nagoya Univ Hosp, Dept Transfus Med, Nagoya, Aichi, Japan
[8] Nagoya Univ, Grad Sch Med, Div Mol Pathol, Ctr Neural Dis & Canc, Nagoya, Aichi, Japan
[9] Nagoya Natl Hosp, Nagoya, Aichi, Japan
基金
日本学术振兴会;
关键词
May-Hegglin anomaly; Sebastian syndrome; Fechtner syndrome; Epstein syndrome; MYH9; targeted gene disruption; knockout mouse; thrombocytopenia; platelet; neutrophil;
D O I
10.1016/j.bbrc.2004.10.147
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Among three different isoforms of non-muscle myosin heavy chains (NMMHCs), only NMMHCA is associated with inherited human disease, called MYH9 disorders, characterized by macrothrombocytopenia and characteristic granulocyte inclusions. Here targeted gene disruption was performed to understand fundamental as well as pathological role of the gene for NMMHCA, MYH9. Heterozygous intercrosses yielded no homozygous animals among 552 births, suggesting that MYH9 expression is required for embryonic development. In contrast, MYH9+/- mice were viable and fertile without gross anatomical, hematological, and nephrological abnormalities. Immunofluorescence analysis also showed the normal cytoplasmic distribution of NMMHCA. We further measured the auditory brainstem response and found two of six MYH9+/- mice had hearing losses, whereas the remaining four were comparable to wild-type mice. Such observation may parallel the diverse expression of Alport's manifestations of human individuals with MYH9 disorders and suggest the limited requirement of the gene for maintenance and function of specific organs. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1163 / 1171
页数:9
相关论文
共 34 条
[21]  
MAUPIN P, 1994, J CELL SCI, V107, P3077
[22]  
Meleg-Smith S, 2001, ULTRASTRUCT PATHOL, V25, P193
[23]   Cloning and development expression of nonmuscle myosin IIA (Myh9) in the mammalian inner ear [J].
Mhatre, AN ;
Li, L ;
Kim, Y ;
Coling, DE ;
Lalwani, AK .
JOURNAL OF NEUROSCIENCE RESEARCH, 2004, 76 (03) :296-305
[24]   P-selectin-dependent macrophage migration into the tubulointerstitium in unilateral ureteral obstruction [J].
Naruse, T ;
Yuzawa, Y ;
Akahori, T ;
Mizuno, M ;
Maruyama, S ;
Kannagi, R ;
Hotta, N ;
Matsuo, S .
KIDNEY INTERNATIONAL, 2002, 62 (01) :94-105
[25]   Myosins: a diverse superfamily [J].
Sellers, JR .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2000, 1496 (01) :3-22
[26]  
Seri M, 2000, NAT GENET, V26, P103
[27]   MYH9-related disease - May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness [J].
Seri, M ;
Pecci, A ;
Di Bari, F ;
Cusano, R ;
Savino, M ;
Panza, E ;
Nigro, A ;
Noris, P ;
Gangarossa, S ;
Rocca, B ;
Gresele, P ;
Bizzaro, N ;
Malatesta, P ;
Koivisto, PA ;
Longo, I ;
Musso, R ;
Pecoraro, C ;
Iolascon, A ;
Magrini, U ;
Soriano, JR ;
Renieri, A ;
Ghiggeri, GM ;
Ravazzolo, R ;
Balduini, CL ;
Savoia, A .
MEDICINE, 2003, 82 (03) :203-215
[28]   Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene [J].
Seri, M ;
Savino, M ;
Bordo, D ;
Cusano, R ;
Rocca, B ;
Meloni, I ;
Di Bari, F ;
Koivisto, PA ;
Bolognesi, M ;
Ghiggeri, GM ;
Landolfi, R ;
Balduini, CL ;
Zelante, L ;
Ravazzolo, R ;
Renieri, A ;
Savoia, A .
HUMAN GENETICS, 2002, 110 (02) :182-186
[29]   Ablation and mutation of nonmuscle myosin heavy chain II-B results in a defect in cardiac myocyte cytokinesis [J].
Takeda, K ;
Kishi, H ;
Ma, XF ;
Yu, ZX ;
Adelstein, RS .
CIRCULATION RESEARCH, 2003, 93 (04) :330-337
[30]   Nonmuscle myosin II-B is required for normal development of the mouse heart [J].
Tullio, AN ;
Accili, D ;
Ferrans, VJ ;
Yu, ZX ;
Takeda, K ;
Grinberg, A ;
Westphal, H ;
Preston, YA ;
Adelstein, RS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (23) :12407-12412